Tectonic Therapeutic Inc. Insider Trading
TECX
Insiders bought 182K and sold 651K on the open market.
All of the selling was scheduled in advance under 10b5-1 plans.
Get an email when TECX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30 | Peter McNamara Chief Scientific Officer | Sold10b5-1 plan | 536 | $23.04 | 12K | 1.0% | Form 4 |
| Aug 25 | Peter McNamara Chief Scientific Officer | Sold10b5-1 plan | 43 | $36.52 | 2K | <0.1% | Form 4 |
| Aug 12 | Peter McNamara Chief Scientific Officer | Sold10b5-1 plan | 43 | $35.00 | 2K | <0.1% | Form 4 |
| Jun 30 | Peter McNamara Chief Scientific Officer | Sold10b5-1 plan | 172 | $35.00 | 6K | 0.3% | Form 4 |
| May 4 | Marcella K. Ruddy Chief Medical Officer | Sold10b5-1 plan | 1,065 | $30.00 | 32K | 1.5% | Form 4 |
| Apr 1 | Marcella K. Ruddy Chief Medical Officer | Sold10b5-1 plan | 1,000 | $31.05 | 31K | 1.4% | Form 4 |
| Mar 6 | Marcella K. Ruddy Chief Medical Officer | Sold10b5-1 plan | 10,000 | $30.00 | 300K | 13% | Form 4 |
| Mar 6 | Peter McNamara Chief Scientific Officer | Sold10b5-1 plan 2 parts | 6,262 | $30.17 average | 189K | 10% | Form 4 |
| Mar 3 – 4 | Peter McNamara Chief Scientific Officer | Sold10b5-1 plan 2 parts | 3,299 | $23.53 average | 78K | 5.3% | Form 4 |
| Feb 11 | Alise Reicin Chief Executive Officer | Bought | 2,500 | $21.10 | 53K | 0.7% | Form 4 |
| Feb 10 | Daniel Lochner Chief Financial Officer | Bought | 6,000 | $21.61 | 130K | 23% | Form 4 |
| Apr 9, 2025 – Apr 11, 2025 | Timothy A Springer Director | Bought 8 parts | 141,923 | $16.20 average | $2.3M | 2.4% | Form 4 |
| Apr 7, 2025 | Timothy A Springer Director | Bought 2 parts | 500,000 | $17.10 average | $8.55M | 9.3% | Form 4 |
| Apr 7, 2025 | Terrance McGuire Director | SoldNo plan | 500,000 | $17.10 | $8.55M | 47% | Form 4 |
| Feb 5, 2025 | Timothy A Springer Director | Bought 2 parts | 789,294 | $50.68 average | $40M | 17% | Form 4 |
| Feb 5, 2025 | Daniel Lochner Chief Financial Officer | Bought | 4,617 | $54.14 | 250K | New | Form 4 |
- Sep 3010b5-1 planPeter McNamaraChief Scientific Officer · sold 536 at $23.0412K1.0% of stake
- Aug 2510b5-1 planPeter McNamaraChief Scientific Officer · sold 43 at $36.522K<0.1% of stake
- Aug 1210b5-1 planPeter McNamaraChief Scientific Officer · sold 43 at $35.002K<0.1% of stake
- Jun 3010b5-1 planPeter McNamaraChief Scientific Officer · sold 172 at $35.006K0.3% of stake
- May 410b5-1 planMarcella K. RuddyChief Medical Officer · sold 1,065 at $30.0032K1.5% of stake
- Apr 110b5-1 planMarcella K. RuddyChief Medical Officer · sold 1,000 at $31.0531K1.4% of stake
- Mar 610b5-1 planMarcella K. RuddyChief Medical Officer · sold 10,000 at $30.00300K13% of stake
- Mar 610b5-1 planPeter McNamaraChief Scientific Officer · sold 6,262 at avg $30.17189K10% of stake
- Mar 3 – 410b5-1 planPeter McNamaraChief Scientific Officer · sold 3,299 at avg $23.5378K5.3% of stake
- Feb 11Alise ReicinChief Executive Officer · bought 2,500 at $21.1053K0.7% of stake
- Feb 10Daniel LochnerChief Financial Officer · bought 6,000 at $21.61130K23% of stake
- Apr 9, 2025 – Apr 11, 2025Timothy A SpringerDirector · bought 141,923 at avg $16.20$2.3M2.4% of stake
- Apr 7, 2025Timothy A SpringerDirector · bought 500,000 at avg $17.10$8.55M9.3% of stake
- Apr 7, 2025No planTerrance McGuireDirector · sold 500,000 at $17.10$8.55M47% of stake
- Feb 5, 2025Timothy A SpringerDirector · bought 789,294 at avg $50.68$40M17% of stake
- Feb 5, 2025Daniel LochnerChief Financial Officer · bought 4,617 at $54.14250KNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with TECX
Held by ETFs
TECX is in 10 US ETFs. The largest of them, with TECX's weight in each:
Spot a number that looks wrong? Check it in TECX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing TECX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.